Genetic testing for infantile-onset epilepsies in resource-limited settings

Area of Science:

• Pediatric Neurology
• Medical Genetics
• Global Health

Background:

• Infantile-onset epilepsies are a diverse group of conditions with onset in early childhood.
• Genetic variations are a common cause of these epilepsies, exhibiting genetic heterogeneity and phenotypic pleiotropy.
• Precision medicine necessitates early genetic diagnosis for effective management and improved developmental outcomes.

Purpose of the Study:

• To review the importance, challenges, and strategies for integrating genetic testing for infantile-onset epilepsies.
• To highlight the specific difficulties in resource-limited environments.
• To emphasize the need for accessible and affordable genetic diagnostic solutions.

Main Methods:

• Literature review focusing on genetic testing in infantile-onset epilepsies.
• Analysis of barriers to genetic diagnosis in resource-limited settings.
• Exploration of strategies to overcome these barriers.

Main Results:

• Genetic testing is vital for diagnosing infantile-onset epilepsies but faces significant access challenges globally, particularly in resource-limited areas.
• High costs, limited laboratory access, and the need for expert interpretation are major barriers.
• Strategies like targeted gene panels, collaborations, and phenotyping can improve diagnostic yield.

Conclusions:

• Integrating genetic testing into resource-limited settings requires addressing cost and accessibility barriers.
• Investments in infrastructure, policy, and international collaboration are essential.
• Affordable and accessible genetic solutions are critical for timely diagnosis and enhanced patient care in infantile-onset epilepsies.